Detecting the Prevalence of Hepatitis C Virus among Iraqi People

ORIGINAL ARTICLE
Hasan Abd Ali Khudhair, Ali A. H. Albakaa, Khwam R. Hussein

 
International Journal of Biomedicine. 2023;13(2):234-240.
DOI: 10.21103/Article13(2)_OA5
Originally published June 5, 2023

Abstract: 

Background: Infection with the hepatitis C virus (HCV) is a major public health issue worldwide and remains a vital etiology of long-term hepatitis. This study aimed to detect the prevalence of HCV infection among Iraqi people. This research was proposed to detect the frequency of HCV infection in renal failure patients, thalassemia patients, blood donors, and Iraqi medical staff. Such prevalence potentially could assist in the development of a preventive program for this infection and orient future studies.
Methods and Results: Cross-sectional research was conducted in Thi-Qar Province (Iraq). The enrolled 1650 individuals (1180 males and 470 females, age range of 1-85 years) were classified into four study groups. Group 1 included 120 patients with renal failure, Group 2 included 220 patients suffering from thalassemia, Group 3 included 1259 blood donor subjects, and Group 4 included 51 subjects from the medical staff. Serum anti-HCV-IgG-Abs were detected qualitatively by a human HCV-IgG-ELISA Kit (MyBioSource, USA). The findings revealed that out of 1650 subjects, only 53(3.2%) were infected with HCV. The highest prevalence was reported among thalassemia patients 34/220(15.45%), followed by renal failure patients 8/120(6.66%) and then the medical staff group 3/51(5.88%), whereas the lowest prevalence was reported among the blood donor group 8/1259(0.64%). The total infection rate of HCV was higher among males [33/53(62.3%)] than females [20/53(37.7%)], with significant differences (P<0.05). We found a significant difference in HCV infection rate according to the age range of the study subjects (P<0.05). The higher infection percentages of 29/53(54.7%) and 15/53(28.3%) were found in age groups of 1-20 years and 21-40 years, respectively, followed by the age group of 41-60 years, which had infection percentages of 7/53(13.2%), while the lowest infection rate was reported in the age group of more than 60 years, which was 2/53(3.8%).
Conclusion: The frequency rate of HCV infection among Iraqi people is similar to those in most Asian and non-Asian studied populations, and the infection rate was higher in males and inversely correlated with the age of the subjects. The main routes of HCV infection were blood transfusions, renal dialysis, and HCWs. Thalassemic and hemodialysis patients were potentially vulnerable to HCV infection. Effective screening methods and blood donor screening protocols are likely required to prevent the spread of HCV infection.

Keywords: 
hepatitis C virus • blood transfusions • thalassemia • renal dialysis
References: 
  1. Li HC, Lo SY. Hepatitis C virus: Virology, diagnosis and treatment. World J Hepatol. 2015 Jun 8;7(10):1377-89. doi: 10.4254/wjh.v7.i10.1377. 
  2. Han R, Zhou J, François C, Toumi M. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update. BMC Infect Dis. 2019 Jul 23;19(1):655. doi: 10.1186/s12879-019-4284-9. 
  3. Hussein NR, Balatay AA, Sezgin AT, Jawad RS. The distribution of HCV in subjects attending hospitals in Duhok City, Iraq. Asian Pacific Journal of Tropical Biomedicine. 2017;7(3):262-4.
  4. Warkad SD, Song KS, Pal D, Nimse SB. Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies. Sensors (Basel). 2019 Sep 30;19(19):4257. doi: 10.3390/s19194257.
  5. Kesli R. Evaluation of assay methods and false positive results in the laboratory diagnosis of hepatitis C virus infection. Archives of Clinical Microbiology. 2011;2(4):1.
  6. Khedmat H, Amini M, Ghamar-Chehreh ME, Agah S. Hepatitis C virus infection in dialysis patients. Saudi J Kidney Dis Transpl. 2014 Jan;25(1):1-8. doi: 10.4103/1319-2442.124455.
  7. Fabrizi F. Hepatitis C virus infection and dialysis: 2012 update. ISRN Nephrol. 2012 Dec 17;2013:159760. doi: 10.5402/2013/159760.
  8. Boroujerdnia MG, Zadegan MA, Zandian KM, Rodan MH. Prevalence of hepatitis-C virus (HCV) among thalassemia patients in Khuzestan Province, Southwest Iran. Pakistan Journal of Medical Sciences Old. 2009;25(1):113-7.
  9. Najim OA, Hassan MK. Prevalence of hepatitis C virus seropositivity among multitransfused patients with hereditary anemias in Basra, Iraq. Iraqi Journal of Hematology. 2018;7(1): 39.
  10. Khodabandehloo M, Roshani D, Sayehmiri K. Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis. J Res Med Sci. 2013 Aug;18(8):674-82. 
  11. Alhilfi HS, Alhashimi RA, Alsaad RK. Seroprevalence of hepatitis B and hepatitis C virus among blood donors in missan governorate-Iraq. International Journal of Innovation and Applied Studies. 2015;11(3):816-20.
  12. Abdelrheem SS, Saleh YY, Abdelatif HA, Elbadry MM. Hepatitis C infection among health care workers in Aswan: seroprevalence and risk factors. Journal of High Institute of Public Health. 2020;50(1):58-64.
  13. Tarky AM, Akram WA, Al-Naaimi AS, Omer AR. Epidemiology of viral hepatitis B and C in Iraq: a national survey 2005-2006. Zanco Journal of Medical Sciences. 2013;17(1):370-380.
  14. Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015 Jan;61(1):77-87. doi: 10.1002/hep.27259. 
  15. Vriend HJ, Van Veen MG, Prins M, Urbanus AT, Boot HJ, Op De Coul EL. Hepatitis C virus prevalence in The Netherlands: migrants account for most infections. Epidemiol Infect. 2013 Jun;141(6):1310-7. doi: 10.1017/S0950268812001884. 
  16. Hamied L, Abdullah RM, Abdullah AM. Seroprevalence of Hepatitis B and Hepatitis C virus infection in Iraq. The New Iraqi Journal of Medicine. 2010;6(3):69-73.
  17. Abdul-Kareem A, Salman A, Addose H, Salih AM, Al-Khaldi A. Seroprevalence of HBc Ag and Anti-HCV positive blood donors in Najaf Governorate. Iraqi Journal of Community Medicine. 2001;14(1):7-11.
  18. Erden S, Büyüköztürk S, Calangu S, Yilmaz G, Palanduz S, Badur S. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Med Princ Pract. 2003 Jul-Sep;12(3):184-8. doi: 10.1159/000070757. 
  19. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol. 2003 Jan;36(1):47-53. doi: 10.1097/00004836-200301000-00015.
  20. Mostafa A, Taylor SM, el-Daly M, el-Hoseiny M, Bakr I, Arafa N, Thiers V, Rimlinger F, Abdel-Hamid M, Fontanet A, Mohamed MK. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections. Liver Int. 2010 Apr;30(4):560-6. doi: 10.1111/j.1478-3231.2009.02204.x.
  21. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S. Seroprevalence of hepatitis C virus: the first population-based study from Iran. Int J Infect Dis. 2010 Sep;14 Suppl 3:e113-6. doi: 10.1016/j.ijid.2009.11.032.
  22. Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H, Elshazly M, Esmat G, Guan R, Han KH, Koike K, Largen A, McCaughan G, Mogawer S, Monis A, Nawaz A, Piratvisuth T, Sanai FM, Sharara AI, Sibbel S, Sood A, Suh DJ, Wallace C, Young K, Negro F. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011 Jul;31 Suppl 2:61-80. doi: 10.1111/j.1478-3231.2011.02540.x. 
  23. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005 Sep 15;353(11):1135-46. doi: 10.1056/NEJMra050436. 
  24. Al-Khaffajy AA, Al-Ghazal AT. Prevalence of hepatitis C virus in thalassemia and hemoglobinopathies in Duhok City/Iraq. Research Journal of Medical Sciences. 2019;13(1):1115.
  25. Khalid MD, Abdullah BA. Prevalence of anti-HCV antibodies among thalassemia patients in Mosul City, Iraq. Journal of Life Sciences. 2012;6(5):489-491.
  26. Raham TF, Wahed SS, Alhaddad HN. Prevalence of Hepatitis C among patients with β-thalassemia in Diyala-Iraq. Journal of Techniques. 2011;24(4):113-120.
  27. Al-Greti SH. Prevalence of hepatitis C virus in beta-thalassemia major patients at Karbala governorate. Journal of Babylon University for Pure and Applied Sciences. 2013;21(8):2801-5.
  28. Tarish H, Shakeer H. Hepatitis C infection among children with Beta-Thalassemia major in Babylon center of hereditary blood disorders. Kerbala Journal of Medicine. 2014;7(2):1945-51.
  29. Whittaker S, Carter N, Arnold E, Shehata N, Webert KE, Distefano L, Heddle NM. Understanding the meaning of permanent deferral for blood donors. Transfusion. 2008 Jan;48(1):64-72. doi: 10.1111/j.1537-2995.2007.01483.x. 
  30. Su Y, Norris JL, Zang C, Peng Z, Wang N. Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis. Hemodial Int. 2013 Oct;17(4):532-41. doi: 10.1111/j.1542-4758.2012.00761.x. 
  31. Khattab OS. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi J Kidney Dis Transpl. 2008 Jan;19(1):110-5.
  32. Al-Mashhadani JI. Hepatitis C virus infection among haemodialysis patients in Al-Anbar governorate. Iraqi Journal of Community Medicine. 2006;20(1):20-3.
  33. Méndez-Sánchez N, Motola-Kuba D, Chavez-Tapia NC, Bahena J, Correa-Rotter R, Uribe M. Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol. 2004 Sep;42(9):4321-2. doi: 10.1128/JCM.42.9.4321-4322.2004.
  34. Ramzi ZS, Abdulla AA, Tariq AH, Al-Tawil NG. Prevalence and risk factors for hepatitis C virus infection in hemodialysis pateints in Sulaimani. Zanco Journal of Medical Sciences. 2010;14(1 Special):44-50.
  35. Alavian SM, Einollahi B, Hajarizadeh B, Bakhtiari S, Nafar M, Ahrabi S. Prevalence of hepatitis C virus infection and related risk factors among Iranian haemodialysis patients. Nephrology (Carlton). 2003 Oct;8(5):256-60. doi: 10.1046/j.1440-1797.2003.00166.x. 
  36. Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, Barril G, Scheuermann E, Sonkodi S, Goubau P; HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004 Apr;19(4):904-9. doi: 10.1093/ndt/gfh012. 
  37. Thorburn D, Dundas D, McCruden EA, Cameron SO, Goldberg DJ, Symington IS, Kirk A, Mills PR. A study of hepatitis C prevalence in healthcare workers in the West of Scotland. Gut. 2001 Jan;48(1):116-20. doi: 10.1136/gut.48.1.116.
  38. Alhaj NA, Maktari HM, Shamahy HA, Mouid KA. Hepatitis c virus among health care workers and the risk factors contributing for its infection. International Journal of Scientific Research, 2019; 8(4):34-36.
  39. Ansari AM, Dixit S. Hepatitis C virus infection in health care workers: A clinical study. International Journal of Medical and Health Research. 2017;3(2):41-3.
  40. Shah DK, Jain SS, Khot AA, Gharat AR, Rajadhyaksha GC, Rathi PM. Low prevalence of hepatitis B and C infections among the healthcare workers despite low vaccination coverage for hepatitis B in Mumbai. Indian Journal of Medical Sciences. 2017;69(1):8-12.
  41. Ataallah TM, Hanan KA, Maysoun KS, Sadoon AA. Prevalence of hepatitis B and C among blood donors attending the National Blood Transfusion Center in Baghdad, Iraq from 2006-2009. Saudi Med J. 2011 Oct;32(10):1046-50.
  42. Al-Juboury AW, Salih HA, Al-Assadi MK, Ali AM. Seroprevalence of Hepatitis B and C among blood donors in Babylon Governorate-Iraq. Medical Journal of Babylon. 2010;7(1-2):121-9.
  43. Ameen R, Sanad N, Al-Shemmari S, Siddique I, Chowdhury RI, Al-Hamdan S, Al-Bashir A. Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion. 2005 Dec;45(12):1973-80. doi: 10.1111/j.1537-2995.2005.00635.x. 
  44. Al-Gani FA. Prevalence of HBV, HCV and HIV-1, 2 infections among blood donors in Prince Rashed Ben Al-Hassan hospital in North region of Jordan. International Journal of Biological and Medical Research. 2011;2(4):912-6.
  45. Abdul-Sada KM. Estimation of HCV Genome Genotyping and the Role of Mosquitoes in its Transmission. Ph. D. Thesis, College of Medicine, University of Kufa, Iraq, 2011.
  46. Shakeri MT, Nomani H, Ghayour Mobarhan M, Sima HR, Gerayli S, Shahbazi S, Rostami S, Meshkat Z. The prevalence of hepatitis C virus in mashhad, iran: a population-based study. Hepat Mon. 2013 Mar 12;13(3):e7723. doi: 10.5812/hepatmon.7723.
  47. Sood S, Malvankar S. Seroprevalence of hepatitis B surface antigen, antibodies to the hepatitis C virus, and human immunodeficiency virus in a hospital-based population in jaipur, rajasthan. Indian J Community Med. 2010 Jan;35(1):165-9. doi: 10.4103/0970-0218.62588.
  48. Sheikh MY, Atla PR, Ameer A, Sadiq H, Sadler PC. Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley. Gut Liver. 2013 Jan;7(1):66-73. doi: 10.5009/gnl.2013.7.1.66. 
  49. Sharaf-Eldin S, Salama K, Eldemedresh S, Hassan HMS. and Semsem M. Hepatitis B and C viruses in Egyptian children with malignancy. Journal Medical Sciences. 2007;7(6):1003-1008.
  50. Rushdy O, Moftah F, Zakareya S. Trasmitted transfused viral infections among blood donors during years 2006 and 2007 in suez canal area, Egypt. Vox Sang. 2009;96:86-7.
  51. Anwar MI, Rahman M, Hassan MU, Iqbal M. Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J. 2013 Dec 5;10:351. doi: 10.1186/1743-422X-10-351. 
  52. Hartleb M, Gutkowski K, Zejda JE, Chudek J, Więcek A. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior. Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1288-95. doi: 10.1097/MEG.0b013e328357632a. 
  53. Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G, Burgess M. Hepatitis C prevalence--a nationwide serosurvey. Commun Dis Intell Q Rep. 2004;28(4):517-21.
  54. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333-42. doi: 10.1002/hep.26141. 

Download Article
Received April 11, 2023.
Accepted May 15, 2023.
©2023 International Medical Research and Development Corporation.